Saatja: "Epidemic Intelligence" <
[email protected]>
Saaja: "Gianfranco Spiteri" <
[email protected]>, "Grazina Mirinaviciute" <
[email protected]>, "Hubert Buczkowski" <
[email protected]>, "Jon Bilbatua" <
[email protected]>, "Katja Siling" <
[email protected]>, "Laura Espinosa" <
[email protected]>, "Leonidas Alexakis" <
[email protected]>, "Niamh Tiernan" <
[email protected]>, "Xanthi Andrianou" <
[email protected]>
Teema: ECDC-MS Roundtable 9 October 2025 - Draft agenda for feedback
Kuupäev: 2025-10-07 14:20
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
To: NFPs for Threat Detection, EWRS and IHR, and Operational Contact Points
for Epidemic Intelligence
CC: National Coordinators
Dear colleagues,
Please find attached and at
<https://ecdc365.sharepoint.com/:f:/r/teams/econ_ein/Storage/ECDC-MS%20Roundtable%20meetings/Meeting%20Agendas%20and%20Notes?csf=1&web=1&e=pBbclk>
Meeting Agendas and Notes the draft agenda for this week ECDC-MS Roundtable
meeting. For this meeting, we propose discussing the events mentioned in the
agenda.
We welcome your feedback by 16:00 Stockholm time tomorrow. This will allow
us to share the final agenda before EOB (on Wednesday 8 October 2025).
Shortly we will share the link for the call with NFPs for Threat Detection
and OCPs for Epidemic Intelligence. Please, fill in the excel file with any
other MS expert you would like to participate in the call and forward them
the invitation. Only colleagues included in the excel file will be admitted
to the call (
<https://ecdc365.sharepoint.com/:x:/r/teams/econ_ein/Storage/ECDC-MS%20Roundtable%20meetings/ECDC-MS%20RoundTable%20Meeting%20nonNFP%20or%20OCP%20Participants%20List.xlsx?d=w1159133c10784f6485cb0eb416a8ef03&csf=1&web=1&e=QdMScH>
ECDC-MS RoundTable Meeting nonNFP or OCP Participants List.xlsx).
Following the advice of the compliance officer, the experts from MS can
include also those not nominated for an official ECDC role (see updated
instructions at:
<https://ecdc365.sharepoint.com/:w:/r/teams/econ_ein/Storage/ECDC-MS%20Roundtable%20meetings/WorkingInstructions_InvitingParticipants_ECDC_MS_Roundtable_202505.docx?d=w35aa52461a624676912bfaf4744e9cc2&csf=1&web=1&e=ZJaORV&isSPOFile=1>
WorkingInstructions_InvitingParticipants_ECDC_MS_Roundtable_202505.docx).
If you encounter any issues in accessing any of the files shared (i.e., the
draft agenda or the excel), please, let us know.
Looking forward to seeing you at the meeting and please feel free to reach
out for any clarification.
Kind regards,
Grazina
On behalf of the ECDC Epidemic Intelligence Group
*Please note that only Threat Detection NFPs/OCPs have access to the
Epidemic Intelligence Network SharePoint Site.
European Centre for Disease Prevention and Control (ECDC)
Gustav III:s boulevard 40, 169 73 Solna, Sweden
Phone +46 (0)8 58 60 10 00
www.ecdc.europa.eu
Follow ECDC on:
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly
requested, to, consecutively, refrain from disclosing its content to any
third party, delete it and inform its sender of the erroneous transmittal.
Classified as ECDC NORMAL
553 -25400 0 0 -69606 101701 Meeting Agenda - Draft 0 0 Meeting Agenda - Draft -60551 231737 ECDC-Member States Roundtable meeting 9 October 2025 0 0 ECDC-Member States Roundtable meeting 9 October 2025 Agenda of the ECDC-MS Roundtable meeting of 9 October 2025 EpiPulse/CDTR events - Ebola virus disease – DRC – 2025, ECDC , HERA Note: colleagues from HERA will join the meeting exclusively during the presentation and subsequent discussion concerning Ebola virus disease. However, country representatives are welcome to direct questions to HERA on topics beyond Ebola, should they wish to do so. - TBC Other health events -None Discussion on the events - response to question from MS about available EU/EEA stockpile of medicines and vaccines against Ebola virus infection – HERA Updates on tools ( ad hoc ) -None Any other business - New e-learning available by ECDC Training Essentials of SARS-CoV-2 sequencing and data analysis